Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Breast 2

Conditions

Prostatic Neoplasms 2Breast Neoplasms 2Hot Flashes 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Estetrol × Clear all
NCT02718144 2021-06-18

Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer

Pantarhei Oncology B.V.

Phase 1/2 Completed
12 enrolled
Breast

Breast Neoplasms

NCT03361969 2021-06-18

Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

Pantarhei Oncology B.V.

Phase 2 Completed
63 enrolled
Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT02718378 2017-02-09

Evaluation of Safety and Efficacy of Estetrol in Healthy Men

Pantarhei Oncology B.V.

Phase 1 Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

NCT00464516 2012-07-02

Preoperative Estetrol in Breast Cancer

Pantarhei Bioscience

Phase 2 Completed
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡